In recent years, the field of peptide drug discovery has faced significant challenges, particularly in synthesizing sterically hindered peptides. However, a new protocol published on June 17, 2026, in Nature Protocols may offer a breakthrough solution. Developed by Siyuan Wei, Xuchun Zhang, Yishan Guo, Fa Liu, and Zhu-Jun Yao, this innovative method employs ribosome-mimicking molecular reactors (RMMR) to enhance the efficiency of solid-phase peptide synthesis (SPPS).
Understanding Peptide Synthesis Challenges
Peptides that incorporate N-methylated or α,α-disubstituted amino acids are known for their enhanced drug-like properties, such as increased proteolytic stability and membrane permeability. Despite these advantages, the synthesis of such peptides is notoriously difficult due to their steric hindrance. Traditional methods often fall short in achieving high purity and yield.
The RMMR Approach
The RMMR strategy represents a significant leap forward. By mimicking the natural ribosome’s functionality, these molecular reactors facilitate rapid on-resin acyl transfer, effectively forming amide bonds. This circumvents the kinetically hindered two-phase acylation process present in conventional SPPS, allowing for the efficient synthesis of complex peptide sequences.
“Peptide research continues to evolve, offering promising insights into health and wellness,” experts say, highlighting the growing importance of such advancements.
Practical Implications and Future Directions
The RMMR-SPPS method is not only straightforward to implement but also scalable. It can be adapted for both manual and automated synthesizer formats, making it accessible to a broader range of researchers. The process involves the synthesis of Oxyma-C, a key activating unit in the RMMR structure, and the modification of standard SPPS resin to create RMMR resin.
With crude peptide purities reaching up to 98%, this protocol dramatically surpasses existing methods, paving the way for the discovery of new peptide drug candidates that are orally bioavailable or intracellularly targeted.
This article discusses the innovative approach of using ribosome-mimicking molecular reactors to overcome challenges in synthesizing sterically hindered peptides, presenting a significant advancement in peptide drug discovery. peptide synthesis, ribosome mimicking, sterically hindered peptides.
Disclaimer: The content on this website is for informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making any health-related decisions. Images used in this article are AI-generated illustrations.
